AB0405 ADALIMUMAB THERAPEUTIC DRUG MONITORING TEST VALIDATED FOR MEASURING ABP 501 BIOSIMILAR
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.2360
Abstract: Background Promonitor-ADL test is routinely used to monitor IBD patients treated with adalimumab (ADL). ABP 501 (adalimumab biosimilar; Amgen) was authorised throughout the European Union in March 2017 and has been recently launched in several… read more here.
Keywords: promonitor adl; drug; abp 501; employee ... See more keywords